For the first time, researchers safely and effectively treated cells and mice with ovarian cancer using the CRISPR-Cas9 gene-editing tool plus a newly developed lipid nanoparticle (LNP) delivery system, which targeted and destroyed the cancer cells by genetic manipulation. This new therapeutic strategy has the potential to treat not only other types of cancer, but also genetic diseases and chronic viral infections, the researchers said. The findings were described in the study, “CRISPR-Cas9 genome editing…
You must be logged in to read/download the full post.
The post CRISPR-Cas9 in Lipid Nanoparticles Found to Safely Treat Ovarian Cancer in Mice appeared first on BioNewsFeeds.